PATH-2

 | The Achilles tendon is the most commonly torn tendon. Recovery can take many months, often keeping people off work and sport. Platelet-rich plasma (PRP), made from a patient’s own blood, aims to boost the healing response. It is now widely used in sports medicine, though the evidence about whether it does improve recovery was limited.

The PATH-2 study assessed Platelet Rich Plasma (PRP) injection, compared with a placebo (imitation) injection, to find out of this treatment helps people recover better from a torn Achilles tendon.

External Links

Here are relevant links to the study...

• [Main Study Report] 'Platelet Rich Plasma (PRP) injections for acute Achilles tendon rupture: PATH-2 randomised, placebo controlled, superiority trial' published in BMJ
• [Full Trial Report] 'Platelet-rich plasma injection for adults with acute Achilles tendon rupture: the PATH-2 RCT' published in NIHR Journals Library
• [Summary] 'Plasma and blood cell injections have not shown a benefit for Achilles tendon injury' published in NIHR Evidence
• [Two Year Follow Up] Platelet-rich plasma injection for acute Achilles tendon rupture two-year follow-up of the PATH-2 randomized, placebo-controlled, superiority trial